Bladder Cancer Canada
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
B+
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
69%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 69 cents are available for programs.
My anchor
OVERVIEW
About Bladder Cancer Canada:
Bladder Cancer Canada is a 4-star charity with an above average results reporting grade and reasonable overhead costs. It is financially transparent. With its current reserves, the charity can cover two years and seven months of annual program costs.
Founded in 2009, Bladder Cancer Canada (BCC) aims to improve the level of support available for those diagnosed with the disease. BCC reports there are currently 90,000 Canadians living with bladder cancer with 12,000 diagnoses annually. Bladder cancer is the fifth most common cancer in Canada. BCC reports that it is highly underfunded, ranking 20th out of the top 25 research funded cancers. Due to a high recurrence rate of 60-70%, bladder cancer is also the most expensive cancer type to treat on a per-patient basis.
Bladder Cancer Canada’s mission is three-fold: support bladder cancer patients, increase awareness and education and fund bladder cancer research. These pillars align with the charity’s three program areas: Research, Awareness, and Patient Support.
Awareness represents 52% of program spending in F2022. BCC works with patients, doctors, and the general public to increase awareness about bladder cancer. BCC reports that it had 107,515 website visitors in F2022. It has 2,353 Facebook likes, 2,694 Twitter followers, and 1,044 Instagram followers. BCC reports that its newsletter has 12,728 subscribers.
Research represents 39% of program spending in F2022. BCC reports awarding five grants totaling over $200k and two additional grants totaling $176k in F2022. However, in its financials it only reports spending $251k total for research in F2022.
Bladder Cancer Canada is a major sponsor of CBCIS, which launched in F2014. CBCIS is a database that collects treatment outcome data on bladder cancer patients from 14 health centers across Canada. The goal is to use this data to improve treatment and clinical management practices for patients. The database has information from over 7,000 patients as of F2022. Specifically in F2022, 839 patients were enrolled in the database. There are no grants to CBCIS reported for F2022 and F2021.
In 2020, BCC helped start the Canadian Bladder Cancer Research Network (CBCRN). BCC and CBCRN are related parties as they share a board director and management. The network aims to bring together bladder cancer experts and encourage collaboration between researchers from all of Canada. In F2021 BCC granted $113k to CBCRN. There are no grants to CBCRN reported for F2022.
Patient Support accounts for the final 9% of program spending in F2022. BCC posts online resources, hosts meetings and webinars, runs an online discussion forum, and provides one-to-one support through its One2One program. The online discussion forum had 2,341 users in F2022. There were ten support groups, including three new ones created in F2022. BCC hosted 18 webinars, of which seven were in French.
My anchor
Results and Impact
Bladder Cancer Canada reports that in F2022 it contributed to the approval process by Health Canada of three treatments for bladder cancer: Bavencio, an immunotherapy treatment; Opdivo, a prescription treatment for muscle invasive bladder cancer; and Padcev, a prescription treatment for advanced or metastatic bladder cancer.
While Ci highlights these key results, they may not be a complete representation of Bladder Cancer Canada’s results and impact. This charity is not yet rated on impact (n/r).
My anchor
Finances
Bladder Cancer Canada had donations of $1.1m in F2022. Administrative costs are 12% of revenues (less investment income) and fundraising costs are 19% of donations. This results in total overhead spending of 31%. Overhead spending increased from being 16% in F2021. For every dollar donated, 69 cents go to the cause. This is within Ci’s reasonable range for overhead spending.
BCC had $1.7m in reserve funds in F2022. These are the charity’s cash and investments. The charity has two years and seven months of annual program costs covered by its current reserves.
This charity report is an update that has been sent to Bladder Cancer Canada for review. Changes and edits may be forthcoming.
Updated on August 14, 2023 by Alessandra Castino.
Financial Review
Fiscal year ending December
|
2022 | 2021 | 2020 |
|---|---|---|---|
| Administrative costs as % of revenues | 12.4% | 7.7% | 15.0% |
| Fundraising costs as % of donations | 19.0% | 7.9% | 8.4% |
| Total overhead spending | 31.4% | 15.7% | 23.4% |
| Program cost coverage (%) | 256.1% | 237.9% | 175.0% |
Summary Financial StatementsAll figures in $s |
2022 | 2021 | 2020 |
|---|---|---|---|
| Donations | 1,072,756 | 1,375,028 | 971,161 |
| Government funding | 18,488 | 17,568 | 78,257 |
| Investment income | 19,720 | 5,473 | 3,919 |
| Total revenues | 1,110,964 | 1,398,069 | 1,053,337 |
| Program costs | 649,600 | 537,488 | 657,246 |
| Grants | 0 | 112,505 | 100,000 |
| Administrative costs | 135,457 | 107,466 | 157,428 |
| Fundraising costs | 203,680 | 109,199 | 81,703 |
| Total spending | 988,737 | 866,658 | 996,377 |
| Cash flow from operations | 122,227 | 531,411 | 56,960 |
| Capital spending | 0 | 0 | 0 |
| Funding reserves | 1,663,795 | 1,546,046 | 1,325,474 |
Note: Ci used the spending breakdown provided in BCC's annual report to report program, administrative and fundraising costs. Ci removed the contributions made to CBCIS and CBCRN from total program costs and reported it as grants. Ci adjusted for deferred donations, affecting total revenues by $60k in F2022, $nil in F2021, and $nil in F2020.
Salary Information
$350k + |
0 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
0 |
$160k - $200k |
0 |
$120k - $160k |
1 |
$80k - $120k |
0 |
$40k - $80k |
4 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2022
My anchor
Comments & Contact
Comments added by the Charity:
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 866-674-8889